Project Oncology® CME presents a wide array of oncology CME topics designed to educate and enlighten practitioners on late-breaking discoveries, novel treatment options, evolving methods of patient management, and more. The series provides cutting-edge updates on cancer biology, diagnosis, and multidisciplinary management, as well as evidence-based recommendations to achieve optimal patient outcomes. Each program is designed to be a short, easy-to-digest format of 15 to 30 minutes.
WHIM Syndrome and CXCR4 Variants: New Insights into Cellular Changes That Can Impact Patient Treatment Plans
WHIM Syndrome and CXCR4 Variants: New Insights into Cellular Changes That Can Impact Patient Treatment Plans
Current and Emerging Biomarkers of Response to Immunotherapeutic Regimens
Current and Emerging Biomarkers of Response to Immunotherapeutic Regimens
Optimizing First-Line Immunotherapy for Recurrent or Metastatic HNSCC
Optimizing First-Line Immunotherapy for Recurrent or Metastatic HNSCC
Overcoming Barriers to Equitable Care in HNSCC
Overcoming Barriers to Equitable Care in HNSCC
Managing Immune-Related Adverse Events With Immunotherapies
Managing Immune-Related Adverse Events With Immunotherapies
The Role of Immunotherapy in the Treatment of Recurrent or Metastatic HNSCC: The Evidence
The Role of Immunotherapy in the Treatment of Recurrent or Metastatic HNSCC: The Evidence
